Presentation and outcome of purpura fulminans associated with peripheral gangrene in 12 patients at Mayo Clinic

Journal of the American Academy of Dermatology

Volumn 57, Issue 6, 2007, Pages 944-956

  Davis, Mark D P ^a   Dy, Katrina M ^a   Nelson, Steven ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASPLENIA; CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; DEATH; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FULMINATING PURPURA; GANGRENE; HUMAN; HYPOTENSION; INFECTION; LIMB AMPUTATION; MALE; OLIGURIA; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SHOCK; SKIN BIOPSY; SYMPTOM; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; CHILD; CHILD, PRESCHOOL; DISSEMINATED INTRAVASCULAR COAGULATION; FATAL OUTCOME; FEMALE; GANGRENE; HUMANS; MIDDLE AGED; PURPURA, SCHOENLEIN-HENOCH; RETROSPECTIVE STUDIES;

EID: 36049007453     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.07.039     Document Type: Article

References (43)

1. Davis M.P., Byrd J., Lior T., and Rooke T.W. Symmetrical peripheral gangrene due to disseminated intravascular coagulation. Arch Dermatol 137 (2001) 139-140
2. Schellongowski P., Bauer E., Holzinger U., Staudinger T., Frass M., Laczika K., et al. Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin). Vox Sang 90 (2006) 294-301
3. Vincent J.L., Nadel S., Kutsogiannis D.J., Gibney R.T., Yan S.B., Wyss V.L., et al. Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care (Lond) 9 (2005) R331-R343
4. Kravitz G.R., Dries D.J., Peterson M.L., and Schlievert P.M. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 40 (2005) 941-947
5. Zenz W., Zoehrer B., Levin M., Fanconi S., Hatzis T.D., Knight G., et al., International Paediatric Meningococcal Thrombolysis Study Group. Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: a retrospective study. Crit Care Med 32 (2004) 1777-1780
6. Childers B.J., and Cobanov B. Acute infectious purpura fulminans: a 15-year retrospective review of 28 consecutive cases. Am Surg 69 (2003) 86-90
7. de Kleijn E.D., de Groot R., Hack C.E., Mulder P.G., Engl W., Moritz B., et al. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 31 (2003) 1839-1847
8. Wheeler J.S., Anderson B.J., and De Chalain T.M. Surgical interventions in children with meningococcal purpura fulminans: a review of 117 procedures in 21 children. J Pediatr Surg 38 (2003) 597-603
9. Warner P.M., Kagan R.J., Yakuboff K.P., Kemalyan N., Palmieri T.L., Greenhaigh D.G., et al. Current management of purpura fulminans: a multicenter study. J Burn Care Rehabil 24 (2003) 119-126
10. Ward K.M., Celebi J.T., Gmyrek R., and Grossman M.E. Acute infectious purpura fulminans associated with asplenism or hyposplenism. J Am Acad Dermatol 47 (2002) 493-496
11. Nolan J., and Sinclair R. Review of management of purpura fulminans and two case reports. Br J Anaesth 86 (2001) 581-586
12. White B., Livingstone W., Murphy C., Hodgson A., Rafferty M., and Smith O.P. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 96 (2000) 3719-3724
13. Rintala E., Kauppila M., Seppälä O.P., Voipio-Puikki L.M., Pettilä V., Rasi V., and Kotilainen P. Protein C substitution in sepsis-associated purpura fulminans. Crit Care Med 28 (2000) 2373-2378
14. Ettingshausen C.E., Veldmann A., Beeg T., Schneider W., Jager G., and Kreuz W. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans. Semin Thromb Hemost 25 (1999) 537-541
15. Huang D.B., Price M., Pokorny J., Gabriel K.R., Lynch R., and Paletta C.E. Reconstructive surgery in children after meningococcal purpura fulminans. J Pediatr Surg 34 (1999) 595-601
16. Brown D.L., Greenhalgh D.G., and Warden G.D. Purpura fulminans: a disease best managed in a burn center. J Burn Care Rehabil 19 (1998) 119-123
17. Smith O.P., White B., Vaughan D., Rafferty M., Claffey L., Lyons B., and Casey W. Use of protein-C concentrate, heparin, and hemodiafiltration in meningococcus-induced purpura fulminans. Lancet 350 (1997) 1590-1593
18. Levin M., Eley B.S., Louis J., Cohen H., Young L., and Heyderman R.S. Postinfectious purpura fulminans caused by an autoantibody directed against protein S. J Pediatr 127 (1995) 355-363
19. Rivard G.E., David M., Farrell C., and Schwarz H.P. Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr 126 (1995) 646-652
20. Francis Jr. R.B. Acquired purpura fulminans. Semin Thromb Hemost 16 (1990) 310-325
21. Spicer T.E., and Rau J.M. Purpura fulminans. Am J Med 61 (1976) 566-571
22. DeLoughery T.G. Critical care clotting catastrophes. Crit Care Clin 21 (2005) 531-562
23. Carey M.J., and Rodgers G.M. Disseminated intravascular coagulation: clinical and laboratory aspects. Am J Hematol 59 (1998) 65-73
24. Baker Jr. W.F. Clinical aspects of disseminated intravascular coagulation: a clinician's point of view. Semin Thromb Hemost 15 (1989) 1-57
25. Carpenter C.T., and Kaiser A.B. Purpura fulminans in pneumococcal sepsis: case report and review. Scand J Infect Dis 29 (1997) 479-483
26. Duncan A. New therapies for severe meningococcal disease but better outcomes?. Lancet 350 (1997) 1565-1566
27. de Jonge E., Levi M., Stoutenbeek C.P., and van Deventer S.J. Current drug treatment strategies for disseminated intravascular coagulation. Drugs 55 (1998) 767-777
28. Feinstein D.I. Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood 60 (1982) 284-287
29. Levi M., de Jonge E., van der Poll T., and ten Cate H. Novel approaches to the management of disseminated intravascular coagulation. Crit Care Med 28 Suppl (2000) S20-S24
30. Smith O.P., and White B. Infectious purpura fulminans: diagnosis and treatment. Br J Haematol 104 (1999) 202-207
31. Giudici D., Baudo F., Palareti G., Ravizza A., Ridolfi L., and D'Angelo A. Antithrombin replacement in patients with sepsis and septic shock. Haematologica 84 (1999) 452-460
32. Fourrier F., Jourdain M., and Tournoys A. Clinical trial results with antithrombin III in sepsis. Crit Care Med 28 Suppl (2000) S38-S43
33. Aoki N., Matsuda T., Saito H., Takatsuki K., Okajima K., Takahashi H., et al., CTC-111-IM Clinical Research Group. A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation. Int J Hematol 75 (2002) 540-547
34. Branson H.E., and Katz J. A structured approach to the management of purpura fulminans. J Natl Med Assoc 75 (1983) 821-825
35. Johansen K., and Hansen Jr. S.T. Symmetrical peripheral gangrene (purpura fulminans) complicating pneumococcal sepsis. Am J Surg 165 (1993) 642-645
36. Arrowsmith J.E., Woodhead M.A., Bevan D.H., Nanson E.M., and Cummin A.R. Digital gangrene in small cell lung cancer: response to aspirin treatment. Thorax 46 (1991) 63-64
37. Hayes M.A., Yau E.H., Hinds C.J., and Watson J.D. Symmetrical peripheral gangrene: association with noradrenaline administration. Intensive Care Med 18 (1992) 433-436
38. Denning D.W., Gilliland L., Hewlett A., Hughes L.O., and Reid C.D. Peripheral symmetrical gangrene successfully treated with epoprostenol and tissue plasminogen activator. Lancet 2 (1986) 1401-1402
39. Kullberg B.J., Westendorp R.G., van't Wout J.W., and Meinders A.E. Purpura fulminans and symmetrical peripheral gangrene caused by Capnocytophaga canimorsus (formerly DF-2) septicemia: a complication of dog bite. Medicine (Baltimore) 70 (1991) 287-292
40. Hutchinson J. Severe symmetrical gangrene of the extremities. Br Med J 2 (1891) 8-9
41. Levi M., and Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 341 (1999) 586-592
42. Gamper G., Oschatz E., Herkner H., Paul G., Burgmann H., Janata K., et al. Sepsis-associated purpura fulminans in adults. Wien Klin Wochenschr 113 (2001) 107-112
43. Molos M.A., and Hall J.C. Symmetrical peripheral gangrene and disseminated intravascular coagulation. Arch Dermatol 121 (1985) 1057-1061